Condition
Clinical High Risk for Psychosis (CHR) clinical trials and research
As of November 12, 2026, Find a Trial lists 9 Clinical High Risk for Psychosis (CHR) clinical trials that are recruiting, at sites in 4 countries (most in United States (4), Canada (2), France (2)). By phase: Phase 1/2 (1). The most active sponsors are Centre Psychothérapique de Nancy (2), Icahn School of Medicine at Mount Sinai (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 9Clinical trials
- 4Countries
Newest Clinical High Risk for Psychosis (CHR) clinical trials
All recruiting trials (9)
-
Accelerated Brain Stimulation for Young People at Risk of Psychosis
This study tests a five-day accelerated brain-stimulation treatment to see if it is safe and tolerable for young people at risk for psychosis and to explore biomarkers that might show whether it works.
-
Recovery-oriented suicide prevention for young people at clinical high risk for psychosis
This program tests a peer-supported, clinician-led suicide prevention group for young people at clinical high risk for psychosis to see if it helps reduce suicidal thoughts and support recovery.
-
Mindfulness group experiences for young people at high risk for or early in psychosis
This project tries to understand how group mindfulness sessions feel for French-speaking young people aged 15–30 who are at ultra‑high risk for psychosis or have had a first episode.
-
Biomarker changes after MT1988 dosing in young people at high risk for psychosis
This will test whether two doses of MT1988 taken twice daily for 8 weeks change biomarker tests in 17–30-year-olds at high risk for psychosis compared with placebo.
-
Digital DBT for Youth at Risk of Psychosis
This study tests a self-guided digital DBT program to help young people aged 14–35 who are at clinical high risk for psychosis, comparing it to usual care over eight weeks.
-
French version of the Schizophrenia Proneness Instrument for children and adolescents (SPI-CY)
This project will test the French SPI-CY to see if it reliably identifies French-speaking adolescents (ages 12–17) who are at high risk for developing psychosis.
-
Cognitive training and enhanced treatment for youth at high risk of psychosis in Tunisia
This study is testing two different treatment approaches to see if they can help young people at high risk for psychosis improve their daily functioning over 12 weeks.
-
Telehealth Cognitive Behavioral Therapy for youth at risk for psychosis
This study is testing if online therapy can help young people aged 14-25 who are at risk for psychosis feel better and stay connected with their treatment.
-
Reducing the Time to Start Treatment for First Episode Psychosis through Screenings and Clearer Information
This study tests whether a systematic screening approach plus a clear communication model (ComPsych) can shorten the time from onset to specialty care for people at high risk or experiencing first episode psychosis.
Related topics
Quick answers
How many Clinical High Risk for Psychosis (CHR) clinical trials are recruiting right now?
9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (4 trials), Canada (2 trials), France (2 trials), Tunisia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.